Infliximab in refractory spondyloarthropathies: a multicentre 38 week open study | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article Text

Letter

Infliximab in refractory spondyloarthropathies: a multicentre 38 week open study

https://doi.org/10.1136/ard.2002.004879

Statistics from Altmetric.com

Footnotes

The authors are members of the Spanish Spondyloarthropathy Study Group

Read the full text or download the PDF: